HPCAL1 promotes tumor growth in NSCLC and promotes proliferation in glioblastoma, the latter occurring through activation of the Wnt/β-catenin signaling pathway (Zhang D. et al., 2019; Wang et al., 2022). Here, HPCAL1 is linked to glioblastoma.